THE INFLUENCE OF DIFFERENT VENTILATION PATTERNS ON TREATMENT OF PATIENTS WITH SEVERE TRAUMATIC BRAIN INJURY
Background. Respiratory support is a vital method for temporary compensation of external breathing function in patients with severe traumatic brain injury. However, it is not always possible to deal with severe respiratory dysfunction even with the usage of up-to-date respiratory technologies. This work is aimed to find an answer how different pattern of mechanical ventilation influence on a treatment of patients with severe traumatic brain injury.
Objective. The influence of respiratory support, as a main method for temporary compensation of external breathing function, on treatment result for patients with severe traumatic brain injury.
Methods. Treatment results of 253 patients with severe traumatic brain injury of Ternopil University Hospital were evaluated due to the type of respiratory support used. The results were separately evaluated in alive and dead patients.
Results. Mortality rate of patients depended on the type of mechanical ventilation that was used. The highest mortality (58.69 %) was in the group, when a patient was transferred to forced ventilation a volume control. The mortality rate was decreasing by 51.78% in case of adding PEEP. The strategy of using accessory lung ventilation patterns CPAP and BiPAP caused significant (in 1.48 times) decrease of mortality in this group of patients.
Conclusion The survival of patients with severe traumatic brain injury, who were ventilated by the method of consistent combination of forced ventilation with pressure control (CРV) and 2 patterns of accessory lung ventilation: Constant Positive Airway Pressure (CPAP) and Biphasic positive airway pressure (BiPAP), is reliably higher than in the case of forced ventilation with volume control with Positive end-expiratory pressure.
Bullock R. Neurotrauma. Guidelines for the Management of Severe Traumatic Brain Injury 2007; 24: 101–106.
Churlyaev А. Acute respiratory distress syndrome with severe traumatic brain injury. Common resuscitation 2009; 2: 21-27.
Shekhovtseva K. Epidemiology of traumatic brain injury and the organization of assistance to victims of Stavropol Territory. Dissertation for the candidate of medical sciences: Russian Research Neurosurgical institute - St. Petersburg, 2006. www.dissercat.com.
Saidov S. Violation of hypo coagulating lung function in severe traumatic brain injury. Dissertation for the candidate of medical sciences: Moscow, 2004. www.dissercat.com.
Arabi Y, Haddad S, Tamim H. Mortality Reduction after Implementing a Clinical Practice Guidelines-Based Management Protocol for Severe Traumatic Brain Injury. J CritCare 2010; 25: 190–195.
Lewandowski K, Lewandowski M: Epidemiology of ARDS. Minerva Anestesiol 2006; 72: 473–477.
Eloise M Harman. Acute Respiratory Distress Syndrome Treatment & Management. eMedicineHealth 2014, 2, www// emedicine.medscape.com.
Atul Malhotra. Benefits of Low Tidal Volume Ventilation in ARDS. Crit Care Clin 2008; 18: 79-89.
Luce J. Corticosteroids in ARDS. An evidence-based review. Crit Care Clin 2002; 1: 79-89.
Meduri G. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome. A randomized controlled trial. JAMA 2008; 280: 159–165.
Meduri G. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007; 131: 954–963.
Steinberg K. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2007; 354: 1671–1684.
Meduri G. Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Medicine 2008; 34: 61-69.
Izaguirre-Anariba D. Acute Respiratory Distress Syndrome: A Complex Clinical Condition, Medscape 2015. www. reference.medscape.com
Roberts I, Yates D, Sandercock P. CRASH trial collaborators. Effect of intravenous corticosteroids on death within 14 days in 10008 adults with clinically significant head injury (MRC CRASH trial): randomised placebo-controlled trial. Lancet 2008; 364: 1321–1328.
Martin-Loeches I, Lisboa T, Rhodes A. Use of early corticosteroid therapy on ICU admission in patients affected ey severe pandemic (H1N1) v influenza A infection. Intensive Care Med. 2011; 37(2): 272-83.
MacLaren R, Jung R. Stress-dose corticosteroid therapy for sepsis and acute lung injury or acute respiratory distress syndrome in critically ill adults. Pharmacotherapy 2002; 22: 1140-1156.
Agarwal R, Aggarwal A. Etiology and outcomes of pulmonary and extrapulmonary acute lung injury/ARDS in a respiratory ICU in North India. Chest 2006; 130: 724-729.
Brun-Buisson C, Richard J, Mercat A. Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 2011; 183: 1200-1206.
Authors who sent their manuscript to International Journal of Medicine and Medical Research agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License CC-BY-NC that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).